Matthew K. Szot - Jan 19, 2023 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Financial Officer
Signature
/s/ Matthew Szot
Stock symbol
CVKD
Transactions as of
Jan 19, 2023
Transactions value $
$0
Form type
3
Date filed
1/19/2023, 07:26 PM
Previous filing
Jul 6, 2022
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVKD Common Stock 450K Jan 19, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of restricted common stock, which vest quarterly over a period of two (2) years, subject to certain adjustments.